Abstract

Objective To observe the effects of stromal cell derived factor/CXC chemokine recep- tor (SDF-1α/CXCR4) axis on the expression of CD133 via PI3K/Akt signaling pathway in gastric cancer (GC) in vitro. Methods The morphological expression of CXCR4, Akt, p-Akt and CD133 in KATO-1α cells were detected by using immunocytochemistry. SDF-1α, AMD3100 and LY294002 were respectively used to stimulate/inhibit KATO-m ceils. The semi-quantitative enzyme-linked polymerization assay for CXCR4 and CD133 mRNA expression was applied. The expression levels of CXCR4, Akt, p-Akt and CD133 proteins were detected by using Western blotting. Results Positive staining of CXCR4, Akt, p-Akt and CD133 was observed in the cultured cells. The expression levels of CXCR4 protein (0. 980 ±0. 083), p-Akt protein (0. 770 ± 0. 071 ), and CD133 protein (0. 890 ±0. 078 ) were significantly higher ( P 〈 0. 05) in SDF-1α group than in control group (0. 750 ±0. 042, 0. 680 ±0. 038, 0. 720 ±0. 034 respectively). The expression levels of CD133 mRNA (0. 890 ±0. 061 ) were significantly higher (P 〈 0. 05 ) in SDF-1α group. In AMD3100 group, the expression levels of CXCR4 protein (0. 430 ±0. 055), p-Akt protein (0. 350 ±0. 050) and CD133 protein (0. 110 ±0. 060) were decreased significantly as compared with those in control group (0. 750 ±0. 042, 0. 680 .SO. 038, and 0. 720 ±0. 034 respectively, P 〈0. 05). In LY294002 group, the expression levels of p-Akt protein ( 0. 100 ± 0. 033 ) and CD133 protein (0. 440 ±0. 055 ) were decreased significantly as compared with those in control group (0. 680 ±0. 038 and 0. 720 ± 0. 034 respectively, P 〈0. 05) ; In comparison with that in control group (0. 540 ±0. 036), CD133 mRNA (0. 310 ±0. 021 ) was decreased significantly (P 〈0. 05). Conclusion The axis of SDF-la/CXCR4 stimulated or inhibited can up-regulate or down-regulate the CD133 expression via PI3K/Akt signaling pathway in GC in vitro. Key words: Gastric cancer; Stromal cell derived factor/CXC chemokine receptor; CD133; PI3K/Akt pathway

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call